Specifically, patients exhibiting higher β-catenin expression demonstrated significantly poorer survival outcomes compared to those with low expression, which is further substantiated by the Kaplan-Meier survival curves for the high and low CTNNB1 expression groups in the remaining three cohorts of human lung adenocarcinoma samples (33–36). Here, CTNNB1 is linked to lung adenocarcinoma.